Athenex Valuation
| ATNXDelisted Stock | USD 0 0.00 0.00% |
Athenex seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Athenex from analyzing the firm fundamentals such as return on equity of -19.27, and Profit Margin of (1.01) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Athenex's price fluctuation is very steady at this time. Calculation of the real value of Athenex is based on 3 months time horizon. Increasing Athenex's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Athenex is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Athenex Stock. However, Athenex's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0022 | Real 0.00209 | Hype 0.00275 | Naive 0.17 |
The intrinsic value of Athenex's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Athenex's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Athenex helps investors to forecast how Athenex stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Athenex more accurately as focusing exclusively on Athenex's fundamentals will not take into account other important factors: Athenex Total Value Analysis
Athenex is presently estimated to have valuation of 82.22 M with market capitalization of 2.33 M, debt of 42.36 M, and cash on hands of 23.33 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Athenex fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
82.22 M | 2.33 M | 42.36 M | 23.33 M |
Athenex Investor Information
About 30.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.08. Some equities with similar Price to Book (P/B) outperform the market in the long run. Athenex recorded a loss per share of 10.45. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 15th of February 2023. Based on the key measurements obtained from Athenex's financial statements, Athenex is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Athenex Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Athenex has an asset utilization ratio of 50.39 percent. This suggests that the Company is making $0.5 for each dollar of assets. An increasing asset utilization means that Athenex is more efficient with each dollar of assets it utilizes for everyday operations.Athenex Ownership Allocation
Athenex shows 9.73 percent of its outstanding shares held by insiders and 29.87 percent owned by other corporate entities.Athenex Profitability Analysis
The company reported the previous year's revenue of 102.82 M. Net Loss for the year was (98.97 M) with profit before overhead, payroll, taxes, and interest of 26.7 M.About Athenex Valuation
Our relative valuation model uses a comparative analysis of Athenex. We calculate exposure to Athenex's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Athenex's related companies.Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. Athenex, Inc. was incorporated in 2003 and is headquartered in Buffalo, New York. Athenex operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 652 people.
Athenex Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 6.5 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Athenex Stock
If you are still planning to invest in Athenex check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Athenex's history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |